Company Overview and News

 
New Strong Sell Stocks for April 17th

2018-04-17 zacks
ABM Industries Incorporated (ABM - Free Report) is a provider of integrated facility solutions in the United Sates as well as globally. The Zacks Consensus Estimate for its current year earnings has been revised 8.1% downward over the last 60 days.

1
Wall Street titan Hank Greenberg takes aim at the law that tripped him up

2018-04-16 cnbc
Mr. Greenberg, known as Hank, is a revered figure on Wall Street who built the American International Group into an insurance giant, only to lose it in 2005 amid a securities fraud investigation. He fought the New York attorney general's office for a dozen years before he agreed to pay $9 million as part of a civil settlement last year.

1
The Zacks Analyst Blog Highlights: General Dynamics, Verizon Communications, American International Group, Humana and eBay

2018-04-16 zacks
Chicago, IL – April 16, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include General Dynamics (GD - Free Report) , Verizon Communications (VZ - Free Report) , American International Group (AIG - Free Report) , Humana (HUM - Free Report) and eBay (EBAY - Free Report) .

1
'This is another war': 92yo Wall Street titan takes on authorities

2018-04-15 theage.com.au
Greenberg, known as Hank, is a revered figure on Wall Street who built the American International Group into an insurance giant, only to lose it in 2005 amid a securities fraud investigation. He fought the New York attorney general's office for a dozen years before he agreed to pay $US9 million ($11.6 million) as part of a settlement last year, without admitting guilt.

1
'This is another war': 92yo Wall Street titan takes on authorities

2018-04-15 smh.com.au
Greenberg, known as Hank, is a revered figure on Wall Street who built the American International Group into an insurance giant, only to lose it in 2005 amid a securities fraud investigation. He fought the New York attorney general's office for a dozen years before he agreed to pay $US9 million ($11.6 million) as part of a settlement last year, without admitting guilt.

1
Wall Street Titan Takes Aim at Law That Tripped Him Up - The New York Times

2018-04-15 nytimes
Mr. Greenberg, known as Hank, is a revered figure on Wall Street who built the American International Group into an insurance giant, only to lose it in 2005 amid a securities fraud investigation. He fought the New York attorney general’s office for a dozen years before he agreed to pay $9 million as part of a settlement last year, without admitting guilt.

1
Crisis to Recovery Timeline | Annual Report 2017 | St. Louis Fed

2018-04-14 stlouisfed.org
Geared to a Main Street audience, this e-newsletter will provide a sampling of the latest speeches, research, podcasts, videos, lesson plans and much more. Sign up now to have this emailed to you monthly at no charge.

1
Top Stock Reports for General Dynamics, Verizon & AIG

2018-04-13 zacks
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including General Dynamics (GD), Verizon Communications (VZ) and American International Group (AIG). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

1
A Policymaker's Reflections | Annual Report 2017 | St. Louis Fed

2018-04-13 stlouisfed.org
Geared to a Main Street audience, this e-newsletter will provide a sampling of the latest speeches, research, podcasts, videos, lesson plans and much more. Sign up now to have this emailed to you monthly at no charge.

1
Top 10 Net Payout Yields - April 2018

2018-04-13 seekingalpha
The top net payout yields had a 2% loss in Q1 underperforming the S&P 500 index.

 
Hartford Financial Offers Solution to Combat Cyberattacks

2018-04-10 zacks
The Hartford Financial Services Group, Inc. (HIG - Free Report) has recently launched an admitted cyber liability product named, CyberChoice First Response to address the cyberattacks suffered by the businesses. This initiative comes with an objective to lower the damages caused to the company’s profitability and reputations due to a spate of cyberattacks.

 
A decade after Delta's Northwest merger upended the airline industry

2018-04-07 cnbc
On an afternoon in late October 2008, in a conference room overlooking Delta Air Lines' Atlanta campus, Richard Anderson got word.

 
Swiss Re jumps as SoftBank is said to eye US$9.6b stake

2018-03-29 themalaymailonline
The logo of SoftBank Group Corp is seen at the company’s headquarters in Tokyo, June 30, 2016. — Reuters picLONDON, March 29 — Swiss Re AG jumped after people familiar with the matter said Japan’s SoftBank Group Corp. is edging closer to buying a quarter of the company, valuing the reinsurer at as much as 37 billion francs (approx. RM150 billion).

 
GE: The Time To Buy Is Now

2018-03-28 seekingalpha
If you asked market participants early last year where they see GE 1 year from now I bet almost no-one would have said $13.

 
AIG Paid $67.3 Million in 2017 to Departing CEO and His Successor - WSJ

2018-03-27 wsj
American International Group Inc. paid $67.3 million to its chief executive officers in 2017, with part of the payment going to a man who resigned under pressure early in the year and another portion to attract his successor.

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...